All Articles

Beam Therapeutics is set to unveil pivotal data for its AATD gene editor. Success could transform a disease and validate a multi-billion-dollar platform.

Samsung Bioepis's latest report reveals a thriving biosimilar market, yet deep-seated policy debates over the 340B program threaten to disrupt growth.

As Core Natural Resources preps its Q2 2026 earnings, investors watch to see if powerful merger synergies can defy a volatile global coal market.

The UK fintech's partnership with the century-old NYIF isn't just about training. It’s a strategic move to fuel global expansion with elite talent.

After a blockbuster Q1, BRC Group Holdings faces intense scrutiny. Can its multi-sector strategy weather economic headwinds and justify recent stock volatility?

Life Science Connect's partnership with PMWC moves the 'Davos of Precision Medicine' beyond an annual event, creating a continuous digital and physical ecosystem.

Australian salon giant Just Cuts arrives in Ontario with a walk-in, cuts-only model. But can this hyper-focused strategy succeed in a crowded market?

An Israeli R&D law dramatically inflates Mobileye's profits, masking flat revenue, margin pressure, and a massive $3.8B write-down on its future bets.

A new Microsoft certification for an AI finance tool highlights a quiet revolution: how intelligent software is helping mission-driven organizations navigate chaos.

Brennan Investment Group's latest acquisition in Piedmont, SC highlights a calculated strategy to capitalize on the booming Greenville-Spartanburg market.

A new AI-native operating system from Shanghai aims to replace apps with intelligent agents. Can DroiClaw's radical vision challenge the dominance of Apple and Google?

Viking Therapeutics' appointment of digital health veteran Dorothy Gemmell signals a pivotal shift from lab to market in the crowded weight-loss field.

FutureSports, backed by CME Group and Fenway Sports, is launching tradable indexes based on athlete stats. A new frontier for hedging or a regulatory gamble?

The US$3.6 trillion asset manager is expanding its active ETF lineup, betting that Canadian investors will pay for global expertise over passive indexing.

A Virginia tech firm patented a 'living trust profile' you control. Will this kill data fatigue and protect firms from breaches, or create new digital divides?

Civista Bancshares reports a 30% jump in quarterly profit, showcasing the fruits of its FSB merger and disciplined cost-cutting ahead of a CEO change.

Teladoc One promises a new era of connected care with an AI-driven model and a risky payment structure. Is it the future or a high-stakes gamble?

SBI Life elevates its support for India's para-athletes, a strategic move that aligns brand values with national pride and fuels a burgeoning sports ecosystem.

In a city defined by power cuts, one hotel's move to create its own reliable energy grid reveals a new strategy for resilience and competitive advantage.